Cephalon Anticipates Fentora Launch In Q4
This article was originally published in The Pink Sheet Daily
Executive Summary
Company also looking at 2007 launch for Nuvigil.
You may also be interested in...
Cephalon’s Fentora Approved For Breakthrough Cancer Pain
Barr is free to launch generic of Actiq, Fentora’s predecessor.
Cephalon’s Fentora Approved For Breakthrough Cancer Pain
Barr is free to launch generic of Actiq, Fentora’s predecessor.
See You In September: Cephalon Anticipates Generic Actiq Ahead Of Fentora Follow-On
Barr reports plans to begin selling a generic version of the pain drug in the second half of September.